FYERS
Home
/
Stocks
/
Results
/
Ipca Laboratories Results

Ipca Laboratories Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
13%12%16%8%
28%0%34%51%
21%11%31%48%
14%13%12%16%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
IPCALAB
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
1,997.1₹49809 Cr38.0315.8468.53₹1141 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Less Impairment of Assets
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
———————————————————
₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr
₹3 Cr₹3 Cr₹2 Cr₹0₹0₹0₹12 Cr₹0₹32 L₹0₹0₹0₹0₹0₹14 L₹48 L₹2 Cr₹3 Cr₹3 Cr
₹8035 Cr₹6920 Cr₹6305 Cr₹5817 Cr₹5439 Cr₹4676 Cr₹3590 Cr₹3097 Cr₹2663 Cr₹2430 Cr₹2234 Cr₹2183 Cr₹1934 Cr₹1529 Cr₹1229 Cr₹1026 Cr₹838 Cr₹604 Cr₹561 Cr
₹8035 Cr₹6920 Cr₹6305 Cr₹5817 Cr₹5439 Cr₹4676 Cr₹3590 Cr₹3097 Cr₹2663 Cr₹2430 Cr₹2234 Cr₹2183 Cr₹1934 Cr₹1529 Cr₹1229 Cr₹1026 Cr₹838 Cr₹604 Cr₹561 Cr
₹8064 Cr₹6948 Cr₹6332 Cr₹5842 Cr₹5465 Cr₹4702 Cr₹3627 Cr₹3122 Cr₹2689 Cr₹2455 Cr₹2259 Cr₹2208 Cr₹1960 Cr₹1554 Cr₹1254 Cr₹1052 Cr₹865 Cr₹631 Cr₹589 Cr
₹1460 Cr₹1440 Cr₹1395 Cr₹73 Cr₹77 Cr₹15 Cr₹14 Cr₹16 Cr₹0₹0₹0₹0₹0₹0₹0-₹66 L-₹58 L-₹38 L₹0
₹109 Cr₹543 Cr₹580 Cr₹652 Cr₹395 Cr₹9 Cr₹89 Cr₹134 Cr₹234 Cr₹347 Cr₹434 Cr₹448 Cr₹292 Cr₹366 Cr₹330 Cr₹195 Cr₹364 Cr₹340 Cr₹300 Cr
₹0₹0₹0₹0₹0₹0₹14 Cr₹7 Cr₹0₹5 Cr₹51 Cr₹56 Cr₹2 Cr₹0₹0₹0₹90 Cr₹119 Cr₹53 Cr
₹224 Cr₹278 Cr₹306 Cr₹186 Cr₹162 Cr₹132 Cr₹140 Cr₹146 Cr₹158 Cr₹170 Cr₹156 Cr₹174 Cr₹147 Cr₹130 Cr₹93 Cr₹81 Cr₹79 Cr₹65 Cr₹57 Cr
₹87 Cr₹52 Cr₹41 Cr₹17 Cr₹14 Cr₹10 Cr₹15 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹3 Cr₹71 L₹1 Cr₹2 Cr₹0₹0₹0
₹98 Cr₹96 Cr₹87 Cr₹47 Cr₹43 Cr₹39 Cr₹32 Cr₹25 Cr₹26 Cr₹25 Cr₹20 Cr₹18 Cr₹15 Cr₹12 Cr₹9 Cr₹5 Cr₹0₹0₹0
₹519 Cr₹969 Cr₹1014 Cr₹902 Cr₹614 Cr₹190 Cr₹290 Cr₹313 Cr₹419 Cr₹548 Cr₹663 Cr₹700 Cr₹459 Cr₹510 Cr₹433 Cr₹282 Cr₹534 Cr₹524 Cr₹410 Cr
———————————————————
₹940 Cr₹846 Cr₹776 Cr₹525 Cr₹558 Cr₹665 Cr₹610 Cr₹524 Cr₹423 Cr₹397 Cr₹421 Cr₹307 Cr₹341 Cr₹268 Cr₹235 Cr₹179 Cr₹120 Cr₹94 Cr₹94 Cr
₹732 Cr₹725 Cr₹733 Cr₹488 Cr₹421 Cr₹204 Cr₹305 Cr₹275 Cr₹267 Cr₹316 Cr₹298 Cr₹236 Cr₹251 Cr₹166 Cr₹175 Cr₹100 Cr₹65 Cr₹102 Cr₹43 Cr
₹417 Cr₹495 Cr₹559 Cr₹662 Cr₹368 Cr₹177 Cr₹311 Cr₹210 Cr₹239 Cr₹177 Cr₹185 Cr₹325 Cr₹144 Cr₹157 Cr₹201 Cr₹263 Cr₹0₹0₹0
₹217 Cr₹317 Cr₹288 Cr₹131 Cr₹120 Cr₹115 Cr₹101 Cr₹89 Cr₹78 Cr₹66 Cr₹66 Cr₹36 Cr₹56 Cr₹42 Cr₹29 Cr₹37 Cr₹31 Cr₹111 Cr₹122 Cr
₹2307 Cr₹2384 Cr₹2356 Cr₹1806 Cr₹1466 Cr₹1161 Cr₹1326 Cr₹1098 Cr₹1008 Cr₹956 Cr₹970 Cr₹904 Cr₹791 Cr₹634 Cr₹640 Cr₹579 Cr₹215 Cr₹308 Cr₹259 Cr
₹12350 Cr₹11744 Cr₹11097 Cr₹8623 Cr₹7622 Cr₹6066 Cr₹5258 Cr₹4549 Cr₹4116 Cr₹3960 Cr₹3892 Cr₹3812 Cr₹3211 Cr₹2697 Cr₹2327 Cr₹1912 Cr₹1614 Cr₹1463 Cr₹1259 Cr
₹249 Cr₹235 Cr₹119 Cr₹93 Cr₹70 Cr₹56 Cr₹42 Cr₹40 Cr₹43 Cr₹45 Cr₹44 Cr₹255 Cr₹363 Cr₹317 Cr₹149 Cr₹200 Cr₹184 Cr₹137 Cr₹45 Cr
₹704 Cr₹1302 Cr₹1388 Cr₹1458 Cr₹791 Cr₹252 Cr₹482 Cr₹465 Cr₹628 Cr₹716 Cr₹867 Cr₹935 Cr₹603 Cr₹617 Cr₹601 Cr₹530 Cr₹455 Cr₹459 Cr₹353 Cr
———————————————————
₹7722 Cr₹6995 Cr₹7021 Cr₹4353 Cr₹3749 Cr₹3201 Cr₹2986 Cr₹2633 Cr₹2464 Cr₹2318 Cr₹2177 Cr₹2546 Cr₹1932 Cr₹1579 Cr₹1339 Cr₹988 Cr₹881 Cr₹779 Cr₹579 Cr
₹3095 Cr₹2728 Cr₹2467 Cr₹1602 Cr₹1331 Cr₹1113 Cr₹927 Cr₹692 Cr₹511 Cr₹335 Cr₹163 Cr₹746 Cr₹578 Cr₹475 Cr₹394 Cr₹289 Cr₹243 Cr₹202 Cr₹163 Cr
₹0₹0₹0₹0₹16 Cr₹16 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 L₹2 Cr
₹4627 Cr₹4267 Cr₹4554 Cr₹2751 Cr₹2402 Cr₹2072 Cr₹2059 Cr₹1940 Cr₹1953 Cr₹1983 Cr₹2014 Cr₹1800 Cr₹1354 Cr₹1104 Cr₹944 Cr₹699 Cr₹638 Cr₹577 Cr₹414 Cr
₹762 Cr₹616 Cr₹324 Cr₹122 Cr₹294 Cr₹184 Cr₹71 Cr₹36 Cr₹42 Cr₹62 Cr₹94 Cr₹236 Cr₹149 Cr₹121 Cr₹88 Cr₹88 Cr₹38 Cr₹14 Cr₹128 Cr
₹210 Cr₹216 Cr₹304 Cr₹303 Cr₹270 Cr₹111 Cr₹71 Cr₹30 Cr₹18 Cr₹22 Cr₹26 Cr₹16 Cr₹9 Cr₹9 Cr₹34 Cr₹41 Cr₹32 Cr₹41 Cr₹9 Cr
₹210 Cr₹216 Cr₹304 Cr₹303 Cr₹270 Cr₹111 Cr₹71 Cr₹30 Cr₹18 Cr₹22 Cr₹26 Cr₹16 Cr₹9 Cr₹9 Cr₹34 Cr₹41 Cr₹32 Cr₹41 Cr₹9 Cr
₹336 Cr₹317 Cr₹316 Cr₹230 Cr₹170 Cr₹186 Cr₹128 Cr₹128 Cr₹119 Cr₹106 Cr₹85 Cr₹111 Cr₹78 Cr₹53 Cr₹42 Cr₹39 Cr₹0₹0₹0
₹26 Cr₹53 Cr₹43 Cr₹10 Cr₹16 Cr₹25 Cr₹11 Cr₹6 Cr₹7 Cr₹11 Cr₹16 Cr₹4 Cr₹4 Cr₹5 Cr₹3 Cr₹1 Cr₹0₹0₹0
₹5973 Cr₹5475 Cr₹5558 Cr₹3434 Cr₹3164 Cr₹2629 Cr₹2402 Cr₹2171 Cr₹2170 Cr₹2218 Cr₹2270 Cr₹2198 Cr₹1609 Cr₹1300 Cr₹1117 Cr₹875 Cr₹709 Cr₹632 Cr₹551 Cr
———————————————————
₹633 Cr₹763 Cr₹558 Cr₹323 Cr₹719 Cr₹394 Cr₹238 Cr₹90 Cr₹69 Cr₹114 Cr₹0₹0₹15 L₹15 L₹15 L₹15 L₹15 L₹10 L₹15 L
₹2731 Cr₹2560 Cr₹2471 Cr₹1743 Cr₹1858 Cr₹1595 Cr₹1323 Cr₹1073 Cr₹881 Cr₹882 Cr₹837 Cr₹927 Cr₹848 Cr₹741 Cr₹670 Cr₹466 Cr₹380 Cr₹306 Cr₹268 Cr
₹2014 Cr₹1884 Cr₹1687 Cr₹989 Cr₹911 Cr₹812 Cr₹895 Cr₹682 Cr₹602 Cr₹500 Cr₹446 Cr₹353 Cr₹450 Cr₹418 Cr₹345 Cr₹367 Cr₹388 Cr₹339 Cr₹268 Cr
₹565 Cr₹344 Cr₹297 Cr₹1853 Cr₹641 Cr₹365 Cr₹181 Cr₹282 Cr₹151 Cr₹36 Cr₹176 Cr₹125 Cr₹76 Cr₹58 Cr₹12 Cr₹10 Cr₹11 Cr₹11 Cr₹9 Cr
₹161 Cr₹120 Cr₹325 Cr₹125 Cr₹116 Cr₹78 Cr₹56 Cr₹80 Cr₹68 Cr₹71 Cr₹67 Cr₹80 Cr₹81 Cr₹77 Cr₹91 Cr₹73 Cr₹36 Cr₹0₹0
₹270 Cr₹295 Cr₹197 Cr₹156 Cr₹202 Cr₹193 Cr₹162 Cr₹171 Cr₹174 Cr₹139 Cr₹96 Cr₹129 Cr₹147 Cr₹103 Cr₹92 Cr₹120 Cr₹90 Cr₹175 Cr₹163 Cr
₹6374 Cr₹5967 Cr₹5536 Cr₹5189 Cr₹4447 Cr₹3437 Cr₹2856 Cr₹2378 Cr₹1945 Cr₹1742 Cr₹1622 Cr₹1614 Cr₹1601 Cr₹1397 Cr₹1210 Cr₹1037 Cr₹905 Cr₹831 Cr₹707 Cr
₹4067 Cr₹3583 Cr₹3180 Cr₹3383 Cr₹2981 Cr₹2276 Cr₹1529 Cr₹1280 Cr₹938 Cr₹786 Cr₹652 Cr₹710 Cr₹810 Cr₹764 Cr₹570 Cr₹458 Cr₹690 Cr₹523 Cr₹448 Cr
₹12350 Cr₹11744 Cr₹11097 Cr₹8623 Cr₹7622 Cr₹6066 Cr₹5258 Cr₹4549 Cr₹4116 Cr₹3960 Cr₹3892 Cr₹3812 Cr₹3211 Cr₹2697 Cr₹2327 Cr₹1912 Cr₹1614 Cr₹1463 Cr₹1259 Cr
₹318₹274₹250₹230₹215₹371₹286₹247₹213₹195₹179₹175₹155₹123₹100₹84₹69₹252₹234
₹318₹274₹250₹230₹215₹185₹143₹124₹107₹97₹90₹87₹78₹62₹50₹42₹34₹25₹23

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Cash & Cash Equivalent of Subsidiaries under liquidations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
₹1573 Cr₹1131 Cr₹843 Cr₹745 Cr₹1136 Cr₹1389 Cr₹739 Cr₹546 Cr₹291 Cr₹262 Cr₹117 Cr₹361 Cr₹631 Cr₹454 Cr₹364 Cr₹341 Cr₹266 Cr₹118 Cr₹175 Cr
₹277 Cr₹728 Cr₹490 Cr₹235 Cr₹195 Cr₹183 Cr₹247 Cr₹187 Cr₹193 Cr₹175 Cr₹211 Cr₹189 Cr₹140 Cr₹126 Cr₹157 Cr₹39 Cr₹70 Cr₹147 Cr₹9 Cr
-₹294 Cr-₹176 Cr-₹92 Cr₹49 Cr-₹273 Cr-₹236 Cr-₹264 Cr-₹122 Cr-₹84 Cr-₹104 Cr₹410 Cr-₹6 Cr-₹118 Cr-₹100 Cr-₹87 Cr-₹101 Cr-₹98 Cr-₹90 Cr-₹48 Cr
₹1556 Cr₹1683 Cr₹1241 Cr₹1029 Cr₹1058 Cr₹1336 Cr₹723 Cr₹612 Cr₹399 Cr₹333 Cr₹738 Cr₹543 Cr₹653 Cr₹480 Cr₹434 Cr₹279 Cr₹238 Cr₹176 Cr₹136 Cr
₹1142 Cr₹1321 Cr₹945 Cr₹806 Cr₹856 Cr₹1090 Cr₹570 Cr₹501 Cr₹341 Cr₹282 Cr₹709 Cr₹468 Cr₹522 Cr₹389 Cr₹354 Cr₹214 Cr₹191 Cr₹152 Cr₹106 Cr
-₹247 Cr-₹870 Cr-₹1292 Cr-₹725 Cr-₹855 Cr-₹521 Cr-₹510 Cr-₹165 Cr-₹135 Cr-₹149 Cr-₹218 Cr-₹689 Cr-₹369 Cr-₹260 Cr-₹286 Cr-₹198 Cr-₹117 Cr-₹109 Cr-₹144 Cr
-₹754 Cr-₹283 Cr-₹553 Cr₹507 Cr₹427 Cr-₹306 Cr-₹137 Cr-₹183 Cr-₹130 Cr-₹159 Cr-₹462 Cr₹251 Cr-₹136 Cr-₹83 Cr-₹72 Cr-₹18 Cr-₹74 Cr-₹42 Cr₹37 Cr
₹142 Cr₹169 Cr-₹900 Cr₹588 Cr₹428 Cr₹264 Cr-₹76 Cr₹153 Cr₹75 Cr-₹26 Cr₹29 Cr₹29 Cr₹17 Cr₹46 Cr-₹4 Cr-₹2 Cr₹5 L₹1 Cr-₹71 L
₹925 Cr₹756 Cr₹1579 Cr₹991 Cr₹559 Cr₹295 Cr₹371 Cr₹218 Cr₹143 Cr₹169 Cr₹140 Cr₹74 Cr₹57 Cr₹11 Cr₹9 Cr₹11 Cr₹11 Cr₹9 Cr₹10 Cr
₹0₹0₹77 Cr₹0₹4 Cr₹0₹31 L₹0₹0₹0₹0₹0₹41 L₹0₹2 Cr₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 Cr₹0₹0₹0₹0
₹1066 Cr₹925 Cr₹756 Cr₹1579 Cr₹991 Cr₹559 Cr₹295 Cr₹371 Cr₹218 Cr₹143 Cr₹169 Cr₹104 Cr₹74 Cr₹57 Cr₹11 Cr₹9 Cr₹11 Cr₹11 Cr₹9 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)1,968.90
Volume (₹)2.73 L
High (₹)2,006.90
Upper Circuit2,355.10
Low (₹)1,962.60
Lower Circuit1,570.10
Prev Close1,962.60
52W High (₹)2,038.00
Price1,997.10
52W Low (₹)1,251.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)49808.50 Cr
Div. Yield (%)0.31
PE Ratio38.03
Debt to Equity0.09
Price to Book5.05
Book Value317.72
EPS (TTM)51.63
Face Value1.00
ROE (%)15.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
IPCALABNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
1997.1-12.5 (-0.62%)
1948.50
2037
49,809Cr

Ipca Laboratories Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹694.77Cr; with other income of ₹25.26Cr, profit before interest and tax came to ₹583.96Cr. Interest expense was ₹11.88Cr; PBT before exceptional items stood at ₹572.08Cr. Cost mix (full year): raw materials ₹2540.07Cr; employee cost ₹2160.2Cr; depreciation ₹110.81Cr; other expenses ₹2118.59Cr. Basis: consolidated annual results.

Ipca Laboratories Ltd Quaterly Results Key Takeaways

Ipca Laboratories Ltd reported ₹2788.1Cr total income from operations in Jun 2026, softer than ₹2388.48Cr in Mar 2026 but higher than ₹2308.85Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹694.77Cr; with other income of ₹25.26Cr, profit before interest and tax came to ₹583.96Cr. Interest expense was ₹11.88Cr, taking profit before tax to ₹572.08Cr. After tax of ₹149.27Cr, profit after tax stood at ₹422.81Cr (vs ₹309.4Cr in Mar 2026 and ₹234.42Cr in Jun 2025).